nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—SLC29A1—Mercaptopurine—ulcerative colitis	0.203	0.412	CbGbCtD
Dipyridamole—ABCB1—ulcerative colitis	0.165	1	CbGaD
Dipyridamole—ABCC5—Mercaptopurine—ulcerative colitis	0.155	0.315	CbGbCtD
Dipyridamole—ABCC4—Mercaptopurine—ulcerative colitis	0.0745	0.151	CbGbCtD
Dipyridamole—ABCB1—Methylprednisolone—ulcerative colitis	0.0155	0.0315	CbGbCtD
Dipyridamole—ABCB1—Betamethasone—ulcerative colitis	0.0101	0.0205	CbGbCtD
Dipyridamole—ABCB1—Prednisolone—ulcerative colitis	0.00997	0.0202	CbGbCtD
Dipyridamole—ABCB1—Hydrocortisone—ulcerative colitis	0.00945	0.0192	CbGbCtD
Dipyridamole—ABCB1—Prednisone—ulcerative colitis	0.00942	0.0191	CbGbCtD
Dipyridamole—ABCB1—Dexamethasone—ulcerative colitis	0.00588	0.0119	CbGbCtD
Dipyridamole—PDE11A—epithelium—ulcerative colitis	0.00322	0.0812	CbGeAlD
Dipyridamole—PDE6B—lymphoid tissue—ulcerative colitis	0.00267	0.0672	CbGeAlD
Dipyridamole—PDE7A—lymphoid tissue—ulcerative colitis	0.00221	0.0557	CbGeAlD
Dipyridamole—PRUNE—liver—ulcerative colitis	0.00207	0.0521	CbGeAlD
Dipyridamole—PDE6D—liver—ulcerative colitis	0.002	0.0503	CbGeAlD
Dipyridamole—PDE11A—liver—ulcerative colitis	0.00183	0.046	CbGeAlD
Dipyridamole—PDE6G—liver—ulcerative colitis	0.00176	0.0443	CbGeAlD
Dipyridamole—PDE8A—smooth muscle tissue—ulcerative colitis	0.00173	0.0436	CbGeAlD
Dipyridamole—PDE1A—smooth muscle tissue—ulcerative colitis	0.00168	0.0422	CbGeAlD
Dipyridamole—PDE10A—digestive system—ulcerative colitis	0.00159	0.0401	CbGeAlD
Dipyridamole—PDE7B—liver—ulcerative colitis	0.00142	0.0358	CbGeAlD
Dipyridamole—PDE5A—epithelium—ulcerative colitis	0.00123	0.0309	CbGeAlD
Dipyridamole—PDE2A—liver—ulcerative colitis	0.00119	0.0299	CbGeAlD
Dipyridamole—PDE5A—smooth muscle tissue—ulcerative colitis	0.00118	0.0298	CbGeAlD
Dipyridamole—PDE3A—smooth muscle tissue—ulcerative colitis	0.00115	0.0289	CbGeAlD
Dipyridamole—ADA—lymphoid tissue—ulcerative colitis	0.00114	0.0287	CbGeAlD
Dipyridamole—PDE8B—liver—ulcerative colitis	0.00113	0.0285	CbGeAlD
Dipyridamole—ADA—digestive system—ulcerative colitis	0.00113	0.0284	CbGeAlD
Dipyridamole—PDE3B—liver—ulcerative colitis	0.00111	0.0279	CbGeAlD
Dipyridamole—PDE8A—liver—ulcerative colitis	0.00102	0.0257	CbGeAlD
Dipyridamole—PDE1A—liver—ulcerative colitis	0.000986	0.0248	CbGeAlD
Dipyridamole—PDE5A—digestive system—ulcerative colitis	0.000932	0.0235	CbGeAlD
Dipyridamole—SLC29A1—lymphoid tissue—ulcerative colitis	0.000792	0.02	CbGeAlD
Dipyridamole—SLC29A1—digestive system—ulcerative colitis	0.000783	0.0197	CbGeAlD
Dipyridamole—PDE3A—liver—ulcerative colitis	0.000676	0.017	CbGeAlD
Dipyridamole—ABCC5—liver—ulcerative colitis	0.000635	0.016	CbGeAlD
Dipyridamole—ABCC4—digestive system—ulcerative colitis	0.000591	0.0149	CbGeAlD
Dipyridamole—SLC29A1—liver—ulcerative colitis	0.000583	0.0147	CbGeAlD
Dipyridamole—ABCC4—liver—ulcerative colitis	0.00044	0.0111	CbGeAlD
Dipyridamole—ABCB1—epithelium—ulcerative colitis	0.00027	0.00681	CbGeAlD
Dipyridamole—ABCB1—lymphoid tissue—ulcerative colitis	0.000208	0.00525	CbGeAlD
Dipyridamole—ABCB1—digestive system—ulcerative colitis	0.000206	0.00518	CbGeAlD
Dipyridamole—ABCB1—liver—ulcerative colitis	0.000153	0.00386	CbGeAlD
Dipyridamole—Anxiety—Hydrocortisone—ulcerative colitis	0.000142	0.000965	CcSEcCtD
Dipyridamole—Malaise—Methylprednisolone—ulcerative colitis	0.000141	0.000964	CcSEcCtD
Dipyridamole—Vertigo—Triamcinolone—ulcerative colitis	0.000141	0.000962	CcSEcCtD
Dipyridamole—Hypersensitivity—Mesalazine—ulcerative colitis	0.000141	0.000962	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000141	0.000962	CcSEcCtD
Dipyridamole—Syncope—Triamcinolone—ulcerative colitis	0.000141	0.00096	CcSEcCtD
Dipyridamole—Vertigo—Methylprednisolone—ulcerative colitis	0.000141	0.00096	CcSEcCtD
Dipyridamole—Syncope—Methylprednisolone—ulcerative colitis	0.000141	0.000958	CcSEcCtD
Dipyridamole—Discomfort—Hydrocortisone—ulcerative colitis	0.00014	0.000957	CcSEcCtD
Dipyridamole—Nausea—Budesonide—ulcerative colitis	0.00014	0.000953	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000139	0.00095	CcSEcCtD
Dipyridamole—Oedema—Prednisolone—ulcerative colitis	0.000139	0.00095	CcSEcCtD
Dipyridamole—Dizziness—Azathioprine—ulcerative colitis	0.000139	0.000948	CcSEcCtD
Dipyridamole—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000138	0.000941	CcSEcCtD
Dipyridamole—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000138	0.000939	CcSEcCtD
Dipyridamole—Asthenia—Mesalazine—ulcerative colitis	0.000137	0.000936	CcSEcCtD
Dipyridamole—Shock—Prednisolone—ulcerative colitis	0.000137	0.000935	CcSEcCtD
Dipyridamole—Cough—Triamcinolone—ulcerative colitis	0.000137	0.000934	CcSEcCtD
Dipyridamole—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000136	0.000928	CcSEcCtD
Dipyridamole—Oedema—Hydrocortisone—ulcerative colitis	0.000136	0.000928	CcSEcCtD
Dipyridamole—Convulsion—Triamcinolone—ulcerative colitis	0.000136	0.000928	CcSEcCtD
Dipyridamole—Tachycardia—Prednisolone—ulcerative colitis	0.000136	0.000928	CcSEcCtD
Dipyridamole—Convulsion—Methylprednisolone—ulcerative colitis	0.000136	0.000926	CcSEcCtD
Dipyridamole—Hypertension—Triamcinolone—ulcerative colitis	0.000136	0.000925	CcSEcCtD
Dipyridamole—Pruritus—Mesalazine—ulcerative colitis	0.000135	0.000923	CcSEcCtD
Dipyridamole—Hypertension—Methylprednisolone—ulcerative colitis	0.000135	0.000922	CcSEcCtD
Dipyridamole—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000135	0.000919	CcSEcCtD
Dipyridamole—Shock—Hydrocortisone—ulcerative colitis	0.000134	0.000913	CcSEcCtD
Dipyridamole—Myalgia—Triamcinolone—ulcerative colitis	0.000134	0.000912	CcSEcCtD
Dipyridamole—Vomiting—Azathioprine—ulcerative colitis	0.000134	0.000911	CcSEcCtD
Dipyridamole—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000134	0.00091	CcSEcCtD
Dipyridamole—Arthralgia—Methylprednisolone—ulcerative colitis	0.000133	0.00091	CcSEcCtD
Dipyridamole—Myalgia—Methylprednisolone—ulcerative colitis	0.000133	0.00091	CcSEcCtD
Dipyridamole—Anxiety—Methylprednisolone—ulcerative colitis	0.000133	0.000907	CcSEcCtD
Dipyridamole—Tachycardia—Hydrocortisone—ulcerative colitis	0.000133	0.000906	CcSEcCtD
Dipyridamole—Rash—Azathioprine—ulcerative colitis	0.000133	0.000904	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000133	0.000903	CcSEcCtD
Dipyridamole—Dermatitis—Azathioprine—ulcerative colitis	0.000132	0.000903	CcSEcCtD
Dipyridamole—Flushing—Prednisone—ulcerative colitis	0.000132	0.000902	CcSEcCtD
Dipyridamole—Skin disorder—Hydrocortisone—ulcerative colitis	0.000132	0.000902	CcSEcCtD
Dipyridamole—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000132	0.000902	CcSEcCtD
Dipyridamole—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000132	0.000902	CcSEcCtD
Dipyridamole—Discomfort—Triamcinolone—ulcerative colitis	0.000132	0.000901	CcSEcCtD
Dipyridamole—Discomfort—Methylprednisolone—ulcerative colitis	0.000132	0.000899	CcSEcCtD
Dipyridamole—Headache—Azathioprine—ulcerative colitis	0.000132	0.000898	CcSEcCtD
Dipyridamole—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000132	0.000897	CcSEcCtD
Dipyridamole—Diarrhoea—Mesalazine—ulcerative colitis	0.000131	0.000893	CcSEcCtD
Dipyridamole—Dry mouth—Triamcinolone—ulcerative colitis	0.000131	0.000892	CcSEcCtD
Dipyridamole—Angioedema—Dexamethasone—ulcerative colitis	0.00013	0.000888	CcSEcCtD
Dipyridamole—Angioedema—Betamethasone—ulcerative colitis	0.00013	0.000888	CcSEcCtD
Dipyridamole—Angiopathy—Prednisone—ulcerative colitis	0.000129	0.000882	CcSEcCtD
Dipyridamole—Immune system disorder—Prednisone—ulcerative colitis	0.000129	0.000878	CcSEcCtD
Dipyridamole—Malaise—Dexamethasone—ulcerative colitis	0.000129	0.000876	CcSEcCtD
Dipyridamole—Malaise—Betamethasone—ulcerative colitis	0.000129	0.000876	CcSEcCtD
Dipyridamole—Oedema—Triamcinolone—ulcerative colitis	0.000128	0.000874	CcSEcCtD
Dipyridamole—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000128	0.000874	CcSEcCtD
Dipyridamole—Vertigo—Betamethasone—ulcerative colitis	0.000128	0.000873	CcSEcCtD
Dipyridamole—Vertigo—Dexamethasone—ulcerative colitis	0.000128	0.000873	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000128	0.000872	CcSEcCtD
Dipyridamole—Syncope—Betamethasone—ulcerative colitis	0.000128	0.000871	CcSEcCtD
Dipyridamole—Syncope—Dexamethasone—ulcerative colitis	0.000128	0.000871	CcSEcCtD
Dipyridamole—Arrhythmia—Prednisone—ulcerative colitis	0.000127	0.000868	CcSEcCtD
Dipyridamole—Hypotension—Hydrocortisone—ulcerative colitis	0.000127	0.000867	CcSEcCtD
Dipyridamole—Dizziness—Mesalazine—ulcerative colitis	0.000127	0.000863	CcSEcCtD
Dipyridamole—Shock—Triamcinolone—ulcerative colitis	0.000126	0.00086	CcSEcCtD
Dipyridamole—Alopecia—Prednisone—ulcerative colitis	0.000126	0.000859	CcSEcCtD
Dipyridamole—Shock—Methylprednisolone—ulcerative colitis	0.000126	0.000858	CcSEcCtD
Dipyridamole—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000125	0.000855	CcSEcCtD
Dipyridamole—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000125	0.000854	CcSEcCtD
Dipyridamole—Loss of consciousness—Betamethasone—ulcerative colitis	0.000125	0.000854	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisolone—ulcerative colitis	0.000125	0.000853	CcSEcCtD
Dipyridamole—Tachycardia—Triamcinolone—ulcerative colitis	0.000125	0.000853	CcSEcCtD
Dipyridamole—Nausea—Azathioprine—ulcerative colitis	0.000125	0.000851	CcSEcCtD
Dipyridamole—Tachycardia—Methylprednisolone—ulcerative colitis	0.000125	0.000851	CcSEcCtD
Dipyridamole—Skin disorder—Methylprednisolone—ulcerative colitis	0.000124	0.000847	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000124	0.000846	CcSEcCtD
Dipyridamole—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000124	0.000845	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000124	0.000843	CcSEcCtD
Dipyridamole—Convulsion—Dexamethasone—ulcerative colitis	0.000124	0.000842	CcSEcCtD
Dipyridamole—Convulsion—Betamethasone—ulcerative colitis	0.000124	0.000842	CcSEcCtD
Dipyridamole—Hypertension—Dexamethasone—ulcerative colitis	0.000123	0.000839	CcSEcCtD
Dipyridamole—Hypertension—Betamethasone—ulcerative colitis	0.000123	0.000839	CcSEcCtD
Dipyridamole—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000122	0.000833	CcSEcCtD
Dipyridamole—Vomiting—Mesalazine—ulcerative colitis	0.000122	0.00083	CcSEcCtD
Dipyridamole—Myalgia—Dexamethasone—ulcerative colitis	0.000121	0.000827	CcSEcCtD
Dipyridamole—Myalgia—Betamethasone—ulcerative colitis	0.000121	0.000827	CcSEcCtD
Dipyridamole—Anxiety—Dexamethasone—ulcerative colitis	0.000121	0.000824	CcSEcCtD
Dipyridamole—Anxiety—Betamethasone—ulcerative colitis	0.000121	0.000824	CcSEcCtD
Dipyridamole—Rash—Mesalazine—ulcerative colitis	0.000121	0.000823	CcSEcCtD
Dipyridamole—Dermatitis—Mesalazine—ulcerative colitis	0.000121	0.000822	CcSEcCtD
Dipyridamole—Headache—Mesalazine—ulcerative colitis	0.00012	0.000818	CcSEcCtD
Dipyridamole—Discomfort—Dexamethasone—ulcerative colitis	0.00012	0.000817	CcSEcCtD
Dipyridamole—Discomfort—Betamethasone—ulcerative colitis	0.00012	0.000817	CcSEcCtD
Dipyridamole—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00012	0.000817	CcSEcCtD
Dipyridamole—Hypotension—Methylprednisolone—ulcerative colitis	0.00012	0.000815	CcSEcCtD
Dipyridamole—Pain—Prednisolone—ulcerative colitis	0.000119	0.000813	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000118	0.000801	CcSEcCtD
Dipyridamole—Fatigue—Hydrocortisone—ulcerative colitis	0.000117	0.0008	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000117	0.000796	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000117	0.000794	CcSEcCtD
Dipyridamole—Pain—Hydrocortisone—ulcerative colitis	0.000116	0.000794	CcSEcCtD
Dipyridamole—Oedema—Dexamethasone—ulcerative colitis	0.000116	0.000793	CcSEcCtD
Dipyridamole—Oedema—Betamethasone—ulcerative colitis	0.000116	0.000793	CcSEcCtD
Dipyridamole—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000116	0.000793	CcSEcCtD
Dipyridamole—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000116	0.000793	CcSEcCtD
Dipyridamole—Ill-defined disorder—Prednisone—ulcerative colitis	0.000115	0.000785	CcSEcCtD
Dipyridamole—Paraesthesia—Triamcinolone—ulcerative colitis	0.000115	0.000785	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisolone—ulcerative colitis	0.000115	0.000783	CcSEcCtD
Dipyridamole—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000115	0.000783	CcSEcCtD
Dipyridamole—Anaemia—Prednisone—ulcerative colitis	0.000115	0.000782	CcSEcCtD
Dipyridamole—Shock—Betamethasone—ulcerative colitis	0.000114	0.00078	CcSEcCtD
Dipyridamole—Shock—Dexamethasone—ulcerative colitis	0.000114	0.00078	CcSEcCtD
Dipyridamole—Dyspnoea—Triamcinolone—ulcerative colitis	0.000114	0.000779	CcSEcCtD
Dipyridamole—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000114	0.000778	CcSEcCtD
Dipyridamole—Nervous system disorder—Betamethasone—ulcerative colitis	0.000114	0.000778	CcSEcCtD
Dipyridamole—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000114	0.000776	CcSEcCtD
Dipyridamole—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000114	0.000776	CcSEcCtD
Dipyridamole—Nausea—Mesalazine—ulcerative colitis	0.000114	0.000775	CcSEcCtD
Dipyridamole—Tachycardia—Dexamethasone—ulcerative colitis	0.000114	0.000774	CcSEcCtD
Dipyridamole—Tachycardia—Betamethasone—ulcerative colitis	0.000114	0.000774	CcSEcCtD
Dipyridamole—Angioedema—Prednisone—ulcerative colitis	0.000113	0.000773	CcSEcCtD
Dipyridamole—Dyspepsia—Triamcinolone—ulcerative colitis	0.000113	0.000769	CcSEcCtD
Dipyridamole—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000113	0.000768	CcSEcCtD
Dipyridamole—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000112	0.000767	CcSEcCtD
Dipyridamole—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000112	0.000767	CcSEcCtD
Dipyridamole—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000112	0.000765	CcSEcCtD
Dipyridamole—Malaise—Prednisone—ulcerative colitis	0.000112	0.000763	CcSEcCtD
Dipyridamole—Vertigo—Prednisone—ulcerative colitis	0.000112	0.00076	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000111	0.000759	CcSEcCtD
Dipyridamole—Syncope—Prednisone—ulcerative colitis	0.000111	0.000759	CcSEcCtD
Dipyridamole—Urticaria—Prednisolone—ulcerative colitis	0.000111	0.000755	CcSEcCtD
Dipyridamole—Fatigue—Triamcinolone—ulcerative colitis	0.000111	0.000753	CcSEcCtD
Dipyridamole—Fatigue—Methylprednisolone—ulcerative colitis	0.00011	0.000752	CcSEcCtD
Dipyridamole—Pain—Triamcinolone—ulcerative colitis	0.00011	0.000747	CcSEcCtD
Dipyridamole—Loss of consciousness—Prednisone—ulcerative colitis	0.000109	0.000744	CcSEcCtD
Dipyridamole—Hypotension—Betamethasone—ulcerative colitis	0.000109	0.000741	CcSEcCtD
Dipyridamole—Hypotension—Dexamethasone—ulcerative colitis	0.000109	0.000741	CcSEcCtD
Dipyridamole—Urticaria—Hydrocortisone—ulcerative colitis	0.000108	0.000737	CcSEcCtD
Dipyridamole—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000108	0.000734	CcSEcCtD
Dipyridamole—Convulsion—Prednisone—ulcerative colitis	0.000108	0.000733	CcSEcCtD
Dipyridamole—Hypertension—Prednisone—ulcerative colitis	0.000107	0.000731	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000106	0.000722	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000106	0.000722	CcSEcCtD
Dipyridamole—Arthralgia—Prednisone—ulcerative colitis	0.000106	0.00072	CcSEcCtD
Dipyridamole—Myalgia—Prednisone—ulcerative colitis	0.000106	0.00072	CcSEcCtD
Dipyridamole—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000106	0.00072	CcSEcCtD
Dipyridamole—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000105	0.000719	CcSEcCtD
Dipyridamole—Anxiety—Prednisone—ulcerative colitis	0.000105	0.000718	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000105	0.000715	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000105	0.000713	CcSEcCtD
Dipyridamole—Paraesthesia—Betamethasone—ulcerative colitis	0.000104	0.000712	CcSEcCtD
Dipyridamole—Paraesthesia—Dexamethasone—ulcerative colitis	0.000104	0.000712	CcSEcCtD
Dipyridamole—Discomfort—Prednisone—ulcerative colitis	0.000104	0.000712	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisolone—ulcerative colitis	0.000103	0.0007	CcSEcCtD
Dipyridamole—Dyspepsia—Betamethasone—ulcerative colitis	0.000102	0.000698	CcSEcCtD
Dipyridamole—Dyspepsia—Dexamethasone—ulcerative colitis	0.000102	0.000698	CcSEcCtD
Dipyridamole—Urticaria—Triamcinolone—ulcerative colitis	0.000102	0.000694	CcSEcCtD
Dipyridamole—Urticaria—Methylprednisolone—ulcerative colitis	0.000102	0.000693	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisone—ulcerative colitis	0.000101	0.000691	CcSEcCtD
Dipyridamole—Oedema—Prednisone—ulcerative colitis	0.000101	0.000691	CcSEcCtD
Dipyridamole—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000101	0.000689	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.0001	0.000685	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.0001	0.000685	CcSEcCtD
Dipyridamole—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.0001	0.000684	CcSEcCtD
Dipyridamole—Fatigue—Betamethasone—ulcerative colitis	0.0001	0.000684	CcSEcCtD
Dipyridamole—Fatigue—Dexamethasone—ulcerative colitis	0.0001	0.000684	CcSEcCtD
Dipyridamole—Shock—Prednisone—ulcerative colitis	9.97e-05	0.000679	CcSEcCtD
Dipyridamole—Pain—Dexamethasone—ulcerative colitis	9.95e-05	0.000678	CcSEcCtD
Dipyridamole—Pain—Betamethasone—ulcerative colitis	9.95e-05	0.000678	CcSEcCtD
Dipyridamole—Nervous system disorder—Prednisone—ulcerative colitis	9.94e-05	0.000677	CcSEcCtD
Dipyridamole—Tachycardia—Prednisone—ulcerative colitis	9.89e-05	0.000674	CcSEcCtD
Dipyridamole—Skin disorder—Prednisone—ulcerative colitis	9.84e-05	0.000671	CcSEcCtD
Dipyridamole—Hyperhidrosis—Prednisone—ulcerative colitis	9.79e-05	0.000668	CcSEcCtD
Dipyridamole—Asthenia—Hydrocortisone—ulcerative colitis	9.77e-05	0.000666	CcSEcCtD
Dipyridamole—Pruritus—Hydrocortisone—ulcerative colitis	9.63e-05	0.000657	CcSEcCtD
Dipyridamole—Feeling abnormal—Betamethasone—ulcerative colitis	9.59e-05	0.000653	CcSEcCtD
Dipyridamole—Feeling abnormal—Dexamethasone—ulcerative colitis	9.59e-05	0.000653	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.51e-05	0.000648	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.51e-05	0.000648	CcSEcCtD
Dipyridamole—Hypersensitivity—Triamcinolone—ulcerative colitis	9.45e-05	0.000644	CcSEcCtD
Dipyridamole—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.43e-05	0.000642	CcSEcCtD
Dipyridamole—Diarrhoea—Hydrocortisone—ulcerative colitis	9.32e-05	0.000635	CcSEcCtD
Dipyridamole—Urticaria—Dexamethasone—ulcerative colitis	9.24e-05	0.00063	CcSEcCtD
Dipyridamole—Urticaria—Betamethasone—ulcerative colitis	9.24e-05	0.00063	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Prednisone—ulcerative colitis	9.23e-05	0.000629	CcSEcCtD
Dipyridamole—Dizziness—Prednisolone—ulcerative colitis	9.22e-05	0.000628	CcSEcCtD
Dipyridamole—Asthenia—Triamcinolone—ulcerative colitis	9.2e-05	0.000627	CcSEcCtD
Dipyridamole—Abdominal pain—Dexamethasone—ulcerative colitis	9.2e-05	0.000627	CcSEcCtD
Dipyridamole—Abdominal pain—Betamethasone—ulcerative colitis	9.2e-05	0.000627	CcSEcCtD
Dipyridamole—Asthenia—Methylprednisolone—ulcerative colitis	9.18e-05	0.000626	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisone—ulcerative colitis	9.1e-05	0.00062	CcSEcCtD
Dipyridamole—Pruritus—Triamcinolone—ulcerative colitis	9.07e-05	0.000618	CcSEcCtD
Dipyridamole—Pruritus—Methylprednisolone—ulcerative colitis	9.05e-05	0.000617	CcSEcCtD
Dipyridamole—Dizziness—Hydrocortisone—ulcerative colitis	9e-05	0.000614	CcSEcCtD
Dipyridamole—Dyspepsia—Prednisone—ulcerative colitis	8.92e-05	0.000608	CcSEcCtD
Dipyridamole—Rash—Prednisolone—ulcerative colitis	8.79e-05	0.000599	CcSEcCtD
Dipyridamole—Dermatitis—Prednisolone—ulcerative colitis	8.78e-05	0.000599	CcSEcCtD
Dipyridamole—Diarrhoea—Methylprednisolone—ulcerative colitis	8.75e-05	0.000597	CcSEcCtD
Dipyridamole—Fatigue—Prednisone—ulcerative colitis	8.73e-05	0.000595	CcSEcCtD
Dipyridamole—Headache—Prednisolone—ulcerative colitis	8.73e-05	0.000595	CcSEcCtD
Dipyridamole—Vomiting—Hydrocortisone—ulcerative colitis	8.66e-05	0.00059	CcSEcCtD
Dipyridamole—Rash—Hydrocortisone—ulcerative colitis	8.59e-05	0.000585	CcSEcCtD
Dipyridamole—Dermatitis—Hydrocortisone—ulcerative colitis	8.58e-05	0.000585	CcSEcCtD
Dipyridamole—Headache—Hydrocortisone—ulcerative colitis	8.53e-05	0.000581	CcSEcCtD
Dipyridamole—Dizziness—Triamcinolone—ulcerative colitis	8.48e-05	0.000578	CcSEcCtD
Dipyridamole—Dizziness—Methylprednisolone—ulcerative colitis	8.46e-05	0.000577	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisone—ulcerative colitis	8.35e-05	0.000569	CcSEcCtD
Dipyridamole—Asthenia—Betamethasone—ulcerative colitis	8.35e-05	0.000569	CcSEcCtD
Dipyridamole—Asthenia—Dexamethasone—ulcerative colitis	8.35e-05	0.000569	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Prednisone—ulcerative colitis	8.28e-05	0.000565	CcSEcCtD
Dipyridamole—Nausea—Prednisolone—ulcerative colitis	8.28e-05	0.000565	CcSEcCtD
Dipyridamole—Pruritus—Betamethasone—ulcerative colitis	8.23e-05	0.000561	CcSEcCtD
Dipyridamole—Pruritus—Dexamethasone—ulcerative colitis	8.23e-05	0.000561	CcSEcCtD
Dipyridamole—Vomiting—Triamcinolone—ulcerative colitis	8.15e-05	0.000556	CcSEcCtD
Dipyridamole—Vomiting—Methylprednisolone—ulcerative colitis	8.13e-05	0.000554	CcSEcCtD
Dipyridamole—Nausea—Hydrocortisone—ulcerative colitis	8.09e-05	0.000551	CcSEcCtD
Dipyridamole—Rash—Triamcinolone—ulcerative colitis	8.08e-05	0.000551	CcSEcCtD
Dipyridamole—Dermatitis—Triamcinolone—ulcerative colitis	8.08e-05	0.000551	CcSEcCtD
Dipyridamole—Rash—Methylprednisolone—ulcerative colitis	8.07e-05	0.00055	CcSEcCtD
Dipyridamole—Dermatitis—Methylprednisolone—ulcerative colitis	8.06e-05	0.000549	CcSEcCtD
Dipyridamole—Urticaria—Prednisone—ulcerative colitis	8.05e-05	0.000549	CcSEcCtD
Dipyridamole—Headache—Triamcinolone—ulcerative colitis	8.03e-05	0.000548	CcSEcCtD
Dipyridamole—Headache—Methylprednisolone—ulcerative colitis	8.01e-05	0.000546	CcSEcCtD
Dipyridamole—Abdominal pain—Prednisone—ulcerative colitis	8.01e-05	0.000546	CcSEcCtD
Dipyridamole—Diarrhoea—Dexamethasone—ulcerative colitis	7.96e-05	0.000543	CcSEcCtD
Dipyridamole—Diarrhoea—Betamethasone—ulcerative colitis	7.96e-05	0.000543	CcSEcCtD
Dipyridamole—Dizziness—Betamethasone—ulcerative colitis	7.69e-05	0.000524	CcSEcCtD
Dipyridamole—Dizziness—Dexamethasone—ulcerative colitis	7.69e-05	0.000524	CcSEcCtD
Dipyridamole—Nausea—Triamcinolone—ulcerative colitis	7.62e-05	0.000519	CcSEcCtD
Dipyridamole—Nausea—Methylprednisolone—ulcerative colitis	7.6e-05	0.000518	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisone—ulcerative colitis	7.46e-05	0.000509	CcSEcCtD
Dipyridamole—Vomiting—Dexamethasone—ulcerative colitis	7.4e-05	0.000504	CcSEcCtD
Dipyridamole—Vomiting—Betamethasone—ulcerative colitis	7.4e-05	0.000504	CcSEcCtD
Dipyridamole—Rash—Dexamethasone—ulcerative colitis	7.34e-05	0.0005	CcSEcCtD
Dipyridamole—Rash—Betamethasone—ulcerative colitis	7.34e-05	0.0005	CcSEcCtD
Dipyridamole—Dermatitis—Betamethasone—ulcerative colitis	7.33e-05	0.0005	CcSEcCtD
Dipyridamole—Dermatitis—Dexamethasone—ulcerative colitis	7.33e-05	0.0005	CcSEcCtD
Dipyridamole—Headache—Dexamethasone—ulcerative colitis	7.29e-05	0.000497	CcSEcCtD
Dipyridamole—Headache—Betamethasone—ulcerative colitis	7.29e-05	0.000497	CcSEcCtD
Dipyridamole—Asthenia—Prednisone—ulcerative colitis	7.27e-05	0.000495	CcSEcCtD
Dipyridamole—Pruritus—Prednisone—ulcerative colitis	7.17e-05	0.000489	CcSEcCtD
Dipyridamole—Diarrhoea—Prednisone—ulcerative colitis	6.93e-05	0.000473	CcSEcCtD
Dipyridamole—Nausea—Dexamethasone—ulcerative colitis	6.91e-05	0.000471	CcSEcCtD
Dipyridamole—Nausea—Betamethasone—ulcerative colitis	6.91e-05	0.000471	CcSEcCtD
Dipyridamole—Dizziness—Prednisone—ulcerative colitis	6.7e-05	0.000457	CcSEcCtD
Dipyridamole—Vomiting—Prednisone—ulcerative colitis	6.44e-05	0.000439	CcSEcCtD
Dipyridamole—Rash—Prednisone—ulcerative colitis	6.39e-05	0.000435	CcSEcCtD
Dipyridamole—Dermatitis—Prednisone—ulcerative colitis	6.38e-05	0.000435	CcSEcCtD
Dipyridamole—Headache—Prednisone—ulcerative colitis	6.35e-05	0.000433	CcSEcCtD
Dipyridamole—Nausea—Prednisone—ulcerative colitis	6.02e-05	0.00041	CcSEcCtD
Dipyridamole—PDE3A—GPCR downstream signaling—JAK2—ulcerative colitis	1.75e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—JAK2—ulcerative colitis	1.75e-05	0.000112	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PPARG—ulcerative colitis	1.74e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—STAT3—ulcerative colitis	1.74e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MMP9—ulcerative colitis	1.74e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—RELA—ulcerative colitis	1.73e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—RELA—ulcerative colitis	1.73e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TGFB1—ulcerative colitis	1.73e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TGFB1—ulcerative colitis	1.73e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—NFKB1—ulcerative colitis	1.72e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—STAT3—ulcerative colitis	1.71e-05	0.00011	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CHP1—ulcerative colitis	1.71e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—ulcerative colitis	1.7e-05	0.000109	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ADCY5—ulcerative colitis	1.69e-05	0.000109	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.68e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—TLR4—ulcerative colitis	1.68e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-DRB1—ulcerative colitis	1.68e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL2—ulcerative colitis	1.68e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—IL2—ulcerative colitis	1.68e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—IL6—ulcerative colitis	1.67e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ADRB2—ulcerative colitis	1.67e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—JAK2—ulcerative colitis	1.66e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ADCY5—ulcerative colitis	1.65e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—JAK2—ulcerative colitis	1.65e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.64e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—JAK2—ulcerative colitis	1.64e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—JAK2—ulcerative colitis	1.63e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CXCL8—ulcerative colitis	1.63e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CXCL8—ulcerative colitis	1.63e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TGFB1—ulcerative colitis	1.62e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ICAM1—ulcerative colitis	1.61e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—TGFB1—ulcerative colitis	1.61e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—RELA—ulcerative colitis	1.61e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.6e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—JAK2—ulcerative colitis	1.59e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—CXCL8—ulcerative colitis	1.59e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—JAK2—ulcerative colitis	1.59e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—TGFB1—ulcerative colitis	1.59e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MMP9—ulcerative colitis	1.59e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—STAT3—ulcerative colitis	1.58e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—STAT3—ulcerative colitis	1.58e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—RELA—ulcerative colitis	1.58e-05	0.000102	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—IL2—ulcerative colitis	1.57e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—NFKB1—ulcerative colitis	1.57e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—IL2—ulcerative colitis	1.57e-05	0.000101	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—ALB—ulcerative colitis	1.56e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL2—ulcerative colitis	1.56e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL2—ulcerative colitis	1.56e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CDH1—ulcerative colitis	1.56e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL6—ulcerative colitis	1.55e-05	9.97e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL6—ulcerative colitis	1.55e-05	9.97e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—ulcerative colitis	1.55e-05	9.97e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ADCY5—ulcerative colitis	1.55e-05	9.95e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—STAT3—ulcerative colitis	1.54e-05	9.92e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—RELA—ulcerative colitis	1.54e-05	9.92e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—IL2—ulcerative colitis	1.53e-05	9.81e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ADRB2—ulcerative colitis	1.53e-05	9.81e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL2—ulcerative colitis	1.52e-05	9.78e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CXCL8—ulcerative colitis	1.51e-05	9.72e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ADCY5—ulcerative colitis	1.51e-05	9.68e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—JAK2—ulcerative colitis	1.51e-05	9.67e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.5e-05	9.65e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—JAK2—ulcerative colitis	1.49e-05	9.6e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CXCL8—ulcerative colitis	1.49e-05	9.59e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—CXCL8—ulcerative colitis	1.49e-05	9.58e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MMP9—ulcerative colitis	1.48e-05	9.48e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MMP9—ulcerative colitis	1.48e-05	9.48e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—DLD—ulcerative colitis	1.47e-05	9.47e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.47e-05	9.44e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TGFB1—ulcerative colitis	1.47e-05	9.43e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TGFB1—ulcerative colitis	1.47e-05	9.43e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—NFKB1—ulcerative colitis	1.46e-05	9.38e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—NFKB1—ulcerative colitis	1.46e-05	9.38e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—ulcerative colitis	1.46e-05	9.37e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CXCL8—ulcerative colitis	1.45e-05	9.34e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CXCL8—ulcerative colitis	1.45e-05	9.32e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL2—ulcerative colitis	1.45e-05	9.29e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL6—ulcerative colitis	1.44e-05	9.24e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—IL2—ulcerative colitis	1.44e-05	9.22e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TGFB1—ulcerative colitis	1.43e-05	9.19e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL2—ulcerative colitis	1.43e-05	9.16e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL2—ulcerative colitis	1.43e-05	9.16e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CDH1—ulcerative colitis	1.42e-05	9.15e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—ulcerative colitis	1.42e-05	9.13e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—ulcerative colitis	1.42e-05	9.13e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ADCY5—ulcerative colitis	1.42e-05	9.1e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—STAT3—ulcerative colitis	1.41e-05	9.07e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL2—ulcerative colitis	1.39e-05	8.93e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL2—ulcerative colitis	1.39e-05	8.91e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL6—ulcerative colitis	1.38e-05	8.89e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CXCL8—ulcerative colitis	1.37e-05	8.83e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MMP9—ulcerative colitis	1.37e-05	8.79e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTGS2—ulcerative colitis	1.37e-05	8.79e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—JAK2—ulcerative colitis	1.37e-05	8.78e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—JAK2—ulcerative colitis	1.37e-05	8.77e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CXCL8—ulcerative colitis	1.36e-05	8.76e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—NFKB1—ulcerative colitis	1.35e-05	8.7e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MMP9—ulcerative colitis	1.35e-05	8.67e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IFNG—ulcerative colitis	1.34e-05	8.61e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—NFKB1—ulcerative colitis	1.34e-05	8.58e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—ulcerative colitis	1.33e-05	8.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—RELA—ulcerative colitis	1.32e-05	8.5e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MMP9—ulcerative colitis	1.32e-05	8.45e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL6—ulcerative colitis	1.31e-05	8.44e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—IL2—ulcerative colitis	1.31e-05	8.44e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—STAT3—ulcerative colitis	1.31e-05	8.43e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—STAT3—ulcerative colitis	1.31e-05	8.43e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TGFB1—ulcerative colitis	1.31e-05	8.41e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL2—ulcerative colitis	1.3e-05	8.38e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—NFKB1—ulcerative colitis	1.3e-05	8.36e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL6—ulcerative colitis	1.3e-05	8.36e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL6—ulcerative colitis	1.3e-05	8.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ADCY5—ulcerative colitis	1.3e-05	8.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD4—ulcerative colitis	1.29e-05	8.32e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.27e-05	8.19e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PPARG—ulcerative colitis	1.26e-05	8.12e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—JAK2—ulcerative colitis	1.26e-05	8.1e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—JAK2—ulcerative colitis	1.26e-05	8.1e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—JAK2—ulcerative colitis	1.25e-05	8.03e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CXCL8—ulcerative colitis	1.25e-05	8.02e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TGFB1—ulcerative colitis	1.23e-05	7.89e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IFNG—ulcerative colitis	1.23e-05	7.88e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—STAT3—ulcerative colitis	1.22e-05	7.82e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TGFB1—ulcerative colitis	1.22e-05	7.82e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TGFB1—ulcerative colitis	1.22e-05	7.82e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—IL6—ulcerative colitis	1.21e-05	7.8e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—RELA—ulcerative colitis	1.21e-05	7.77e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—ulcerative colitis	1.21e-05	7.76e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—ulcerative colitis	1.21e-05	7.76e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IL6—ulcerative colitis	1.2e-05	7.72e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—STAT3—ulcerative colitis	1.2e-05	7.71e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—IL6—ulcerative colitis	1.2e-05	7.69e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1B—ulcerative colitis	1.2e-05	7.68e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD4—ulcerative colitis	1.2e-05	7.68e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD4—ulcerative colitis	1.2e-05	7.68e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL2—ulcerative colitis	1.19e-05	7.66e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL2—ulcerative colitis	1.19e-05	7.65e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTGS2—ulcerative colitis	1.19e-05	7.62e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTGS2—ulcerative colitis	1.19e-05	7.62e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD4—ulcerative colitis	1.18e-05	7.61e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—ulcerative colitis	1.18e-05	7.57e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—STAT3—ulcerative colitis	1.17e-05	7.51e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—JAK2—ulcerative colitis	1.15e-05	7.41e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ALB—ulcerative colitis	1.14e-05	7.3e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TGFB1—ulcerative colitis	1.13e-05	7.25e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NFKB1—ulcerative colitis	1.12e-05	7.17e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TGFB1—ulcerative colitis	1.11e-05	7.15e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—ulcerative colitis	1.11e-05	7.11e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—ulcerative colitis	1.11e-05	7.11e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—ulcerative colitis	1.1e-05	7.06e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1B—ulcerative colitis	1.09e-05	7.03e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD4—ulcerative colitis	1.09e-05	7.02e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL2—ulcerative colitis	1.09e-05	7e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—ulcerative colitis	1.09e-05	6.97e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TGFB1—ulcerative colitis	1.08e-05	6.97e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—ulcerative colitis	1.08e-05	6.93e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—ulcerative colitis	1.08e-05	6.92e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.06e-05	6.82e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—JAK2—ulcerative colitis	1.03e-05	6.62e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NFKB1—ulcerative colitis	1.02e-05	6.55e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—ulcerative colitis	1.01e-05	6.5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—STAT3—ulcerative colitis	1e-05	6.44e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—ulcerative colitis	1e-05	6.43e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—ulcerative colitis	1e-05	6.43e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—RELA—ulcerative colitis	9.99e-06	6.42e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.94e-06	6.39e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—ulcerative colitis	9.94e-06	6.38e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	9.91e-06	6.37e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—ulcerative colitis	9.86e-06	6.33e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—JAK2—ulcerative colitis	9.65e-06	6.2e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCL8—ulcerative colitis	9.41e-06	6.05e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—JAK2—ulcerative colitis	9.39e-06	6.03e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—RELA—ulcerative colitis	9.35e-06	6.01e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—ulcerative colitis	9.28e-06	5.96e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—STAT3—ulcerative colitis	9.26e-06	5.95e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—STAT3—ulcerative colitis	9.26e-06	5.95e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—STAT3—ulcerative colitis	9.17e-06	5.89e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—ulcerative colitis	9.17e-06	5.89e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—ulcerative colitis	9.17e-06	5.89e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—ulcerative colitis	9.16e-06	5.88e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—RELA—ulcerative colitis	9.1e-06	5.84e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2—ulcerative colitis	8.99e-06	5.78e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—ulcerative colitis	8.95e-06	5.75e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—ulcerative colitis	8.93e-06	5.73e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—JAK2—ulcerative colitis	8.83e-06	5.67e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL8—ulcerative colitis	8.81e-06	5.66e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	8.74e-06	5.62e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—ulcerative colitis	8.58e-06	5.51e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—ulcerative colitis	8.58e-06	5.51e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL8—ulcerative colitis	8.57e-06	5.51e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RELA—ulcerative colitis	8.55e-06	5.49e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—ulcerative colitis	8.51e-06	5.47e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—ulcerative colitis	8.5e-06	5.46e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—STAT3—ulcerative colitis	8.46e-06	5.44e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NFKB1—ulcerative colitis	8.42e-06	5.41e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2—ulcerative colitis	8.42e-06	5.41e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—ulcerative colitis	8.38e-06	5.39e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—ulcerative colitis	8.38e-06	5.38e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2—ulcerative colitis	8.19e-06	5.26e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—ulcerative colitis	8.17e-06	5.25e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—ulcerative colitis	8.15e-06	5.24e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—JAK2—ulcerative colitis	8.08e-06	5.19e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL8—ulcerative colitis	8.06e-06	5.18e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—ulcerative colitis	7.97e-06	5.12e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NFKB1—ulcerative colitis	7.89e-06	5.07e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—ulcerative colitis	7.85e-06	5.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RELA—ulcerative colitis	7.82e-06	5.03e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—ulcerative colitis	7.75e-06	4.98e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2—ulcerative colitis	7.7e-06	4.95e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NFKB1—ulcerative colitis	7.67e-06	4.93e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—ulcerative colitis	7.66e-06	4.92e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—STAT3—ulcerative colitis	7.57e-06	4.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL8—ulcerative colitis	7.37e-06	4.74e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—ulcerative colitis	7.29e-06	4.68e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NFKB1—ulcerative colitis	7.21e-06	4.63e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS1—ulcerative colitis	7.13e-06	4.58e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—STAT3—ulcerative colitis	7.09e-06	4.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2—ulcerative colitis	7.04e-06	4.53e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—ulcerative colitis	7.02e-06	4.51e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—ulcerative colitis	7.01e-06	4.5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—ulcerative colitis	7e-06	4.5e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—STAT3—ulcerative colitis	6.89e-06	4.43e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—ulcerative colitis	6.67e-06	4.28e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.66e-06	4.28e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NFKB1—ulcerative colitis	6.6e-06	4.24e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—ulcerative colitis	6.57e-06	4.22e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—STAT3—ulcerative colitis	6.48e-06	4.16e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—ulcerative colitis	6.46e-06	4.15e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—ulcerative colitis	6.46e-06	4.15e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CALM3—ulcerative colitis	6.42e-06	4.12e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—ulcerative colitis	6.4e-06	4.11e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—ulcerative colitis	6.39e-06	4.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—ulcerative colitis	6.01e-06	3.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—STAT3—ulcerative colitis	5.93e-06	3.81e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—ulcerative colitis	5.91e-06	3.8e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—ulcerative colitis	5.78e-06	3.71e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—ulcerative colitis	5.49e-06	3.53e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—ulcerative colitis	5.41e-06	3.47e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—ulcerative colitis	5.29e-06	3.4e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—ulcerative colitis	5.26e-06	3.38e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—ulcerative colitis	4.95e-06	3.18e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—ulcerative colitis	4.95e-06	3.18e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—ulcerative colitis	4.81e-06	3.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ADCY5—ulcerative colitis	4.66e-06	2.99e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—ulcerative colitis	4.53e-06	2.91e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—ulcerative colitis	4.52e-06	2.91e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—ulcerative colitis	4.14e-06	2.66e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARG—ulcerative colitis	3.47e-06	2.23e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—ulcerative colitis	3.12e-06	2.01e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.73e-06	1.75e-05	CbGpPWpGaD
